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The	 research	 field	 of	 nanotechnology	 promises	 to	 deliver	 copious	 advantages	 to	 the	 scientific,	
technological	 and	 industrial	 divisions	 globally.	 Most	 notably,	 and	 in	 focus	 in	 this	 chapter,	 is	 the	




the	 adverse	 environmental	 and	 human	 health	 implications	 of	 novel	 ENMs	 particularly	 within	




in	 vivo	 and	 human	 trials	 before	 clinical	 approval	 and	 ultimate	 use.	 This	 chapter	 will	 provide	 an	























and	 enhanced	 imaging	 capabilities	 (Saini	 et	 al.,	 2010).	 The	 size	 reduction	 of	 commonly	 sourced	
materials	 e.g.	 iron	 oxide	 particles	 to	 the	 nano-size	 range	 dramatically	 changes	 their	 surface	 area,	
increasing	 reactivity	 and	 how	 these	 particles	 absorb	 light	 thus	 giving	 rise	 to	 applications	 the	 bulk	
material	does	not	possess.	With	an	estimated	$18.1	billion	invested	in	nanotechnology	in	2014	alone	
(LUX	 research)	 the	United	 States	 plunges	 large	 donations	 towards	 the	medical,	 technological	 and	
consumer	 aspects	 of	 nanotechnology.	 There	 are	 numerous	 examples	 of	 where	 the	 field	 of	
nanoscience	 has	 garnered	 much	 attention	 for	 consumer	 products	 containing	 elements	 of	
nanotechnology	 including	 skin-care	products	 (Gupta	et	 al.,	 2013),	 sporting	equipment	 (Institute	of	
Medicine	Roundtable	on	Environmental	Health	Sciences,	2005),	clothing	(Kulthong	et	al.,	2010)	and	
food	items	(Srinivas	et	al.,	2010).	it	is	the	medical	field	however	which	warrants	the	largest	degree	of	






dots,	 carbon	 nanotubes,	 nanoparticles)	 have	 medical	 applications,	 and	 thus	 far	 have	 been	




Yet	 despite	 an	 elevated	 interest	 in	 nanotheranostics	 and	 the	 proposed	 advantageous	 applications	
there	remains	a	growing	public	concern	as	to	the	potentially	detrimental	health	hazards	associated	
with	engineered	nanomaterial	exposure	(Digesu	et	al.,	2016).	Nanoparticles	may	access	the	body	as	a	






intravenous	 injection	 to	 direct	 skin-contact	 approaches.	 The	 rather	 limited	 data	 available	 on	







purpose	 of	 this	 chapter	 is	 to	 provide	 an	 overview	 of	 the	 current	 knowledge	 encompassing	








(Zhao	 and	 Castranova,	 2011).	 Given	 the	 extensive	 funds	 available	 to	 the	 nanotheranostic	 sector,	
product	manufacture	and	distribution	has	 increased	exponentially;	metal	oxide,	 carbon-based	and	
inorganic	 nanoparticles	 represent	 a	 select	 few	 examples.	 Nanomaterial	 physico-chemical	
characteristics,	specifically	engineered	and	medically-relevant	ones,	can	be	further	functionalised	with	












could	 be	 entirely	 based	 upon	 their	 biodistribution	 capabilities,	 this	 quality	 of	 nanoparticles	 is	
dependant	however	on	features	such	as	morphology,	shape	and	charge,	fortunately	modern	advances	
in	 nanoparticle	 functionalisation	 means	 additional	 targeting	 biodistribution	 can	 be	 engineered	 or	
‘programmed’	into	the	material.	Gold	nanoparticles	for	instance	have	been	explicitly	studied	due	to	
their	 low	 toxicity,	 bio-imaging,	 delivery	 and	 conjugation	 characteristics	 (Tiwari	 et	 al.,	 2014).	With	
simple	modifications	to	the	surface	of	these	particles	with	cell	penetrating	peptides	(CPP)	derived	from	








Nanotheranostic	 materials	 can	 greatly	 differ	 in	 reactivity	 as	 opposed	 to	 their	 macroscopic	
counterparts,	examples	of	each	being	superparamagnetic	iron	oxide	nanoparticles	magnetic	potential	
increases	as	size	decreases	(Lu	et	al.,	2007)	and	graphene	edge	reactivity	 increases	as	atomic	 layer	
number	 approaches	 one	 (Sharma	 et	 al.,	 2010).	 It	 is	 these	 novel,	 tuneable	 properties	 on	 which	
theranostics	 is	 based	however	 these	 features	 could	 be	 inadvertently	 altered	 (reprogrammed)	 in	 a	
biological	environment,	potentially	corrupting	their	intended	therapeutic	function.	Size,	morphology,	









Tinkle,	 2007).	 Associated	with	 oral,	 dermal,	 inhalation	 and	 injection	 routes	 of	 exposure	 there	 are	
currently	three	crucial	elements	to	toxicity	screen	testing	nanomaterials,	namely;	physico-chemical	
characterisation,	in	vitro	assays	both	cellular	and	acellular	and	in	vivo	assays	(Oberdorster	et	al.,	2005).	




environment,	aspects	which	are	not	 feasible	when	 introducing	 in	vivo	 testing.	Finally	Tier	1	 in	vivo	










Especially	 useful	 assays	 are	 able	 to	 quantify	 genetic	 damage	 but	 also	 perform	 analyses	 in	 a	 high	
throughput	manner,	the	cytokinesis	block	micronucleus	(CBMN)	assay	being	a	key	example.	The	CBMN	
assay	relies	on	cell	division	to	exclude	micronuclei	from	the	parent	nucleus,	the	frequency	in	which	
micronuclei	 are	 captured	 during	 cell	 scoring	 provides	 an	 indicator	 of	 genetic	 damage,	 and	 can	 be	
applied	 to	 nanomaterial	 exposures	 (Doak	 et	 al.,	 2012).	 It	 follows,	 there	 is	 a	 clear	 necessity	 for	
nanotoxicology	 research	 to	 inform	 the	 scientific	 development	of	 nanotheranostic	 therapies	 as	 the	







material	 being	 on	 the	 nanoscale	 can	 make	 it	 inherently	 toxic.	 Due	 to	 this	 issue	 the	 first	 step	 of	
nanotoxicology	 study	 is	 full	 physico-chemical	 characterisation	 of	 the	 test	 material.	 These	
characteristics	are	defined	as	being	either	primary	or	secondary,	referring	to	properties	of	the	pristine	

















process	of	corona	 formation	at	 the	NM	surface	can	cause	alteration	of	 the	secondary	structure	of	
attached	proteins	resulting	exposure	of	new	epitopes,	potentially	giving	rise	to	unexpected	biological	
response	(Fleischer	and	Payne,	2014).		Moreover,	corona	formation	will	be	a	determining	factor	in	NM	
hydrodynamic	 diameter,	 agglomeration	 state	 and	 surface	 charge.	 	 Consequently,	 NM-corona	




the	 absorption	 of	 opsonins	 such	 as	 immunoglobulins	 and	 complement	 factors,	 which	 facilitates	







macrophages	 and	 HepG2	 cells	 (human	 hepatocytes).	 Corona	 formation	 by	 incubation	 in	 serum	
resulted	 not	 only	 in	 reduced	 NP	 uptake	 but	 also	 alteration	 of	 the	 primary	 uptake	mechanism	 by	
obstructing	NP-scavenger	receptor	recognition	and	promoting	recognition	by	clathrin.		
Alteration	 of	NP	 uptake	mechanism	due	 to	 corona	 formation	 introduces	 a	major	 challenge	 in	 the	
design	of	targeted	therapeutic	NPs.	In	order	to	facilitate	cell	specific	targeting	by	a	NP	its	surface	is	

































physico-chemical	 characterisation	 is	 essential.	 	 Once	 within	 the	 lung	 a	 NM	 has	 the	 potential	 to	
promote	 a	 chronic	 inflammatory	 response	 and	 subsequently	 lung	 injury.	 And	 at	 the	 cellular	 level	





low	 bioavailability	 because	 dissolution	 rate-limited	 absorption	 typically	 of	 many	 drugs,	 first	 pass	
metabolism	effects,	food	effects	and	short	half-lives	(Gershanik	and	Benita,	2000).	These	are	particular	





Indeed,	 SNLs	 have	 been	 developed	 that	 provide	 a	 notable	 increase	 in	 drug	 bioavailability;	 by	













The	 toxicological	 risk	a	NM	possesses	 is	dependent	on	 its	potential	 to	penetrate	 the	dermal	 layer.	
Typically,	 NMs	 may	 potentially	 penetrate	 the	 skin	 via	 three	 different	 pathways	 intracellularly,	
intracellularly	or	via	dermal	structures	such	as	hair	follicles	(Baroli	et	al.,	2007).		
Depending	it	physico-chemical	characteristics	NM	may	not	be	confined	to	its	target	region	and	maybe	





mechanism	of	NM	translocation	 though	 the	air/blood	barrier	 is	unclear.	 It	 is	 thought	 that	alveolar	
macrophages	play	a	role	in	NM	translocation	by	transporting	NMs	to	the	thoracic	lymph	nodes	(Zhao	
et	 al.,	 2011,	 Shaw	 et	 al.,	 2016).	 It	 is	 also	 speculated	 that	 formation	 of	 a	 NM-protein	 corona	 via	




M-cells	 lining	 intestinal	Peyer’s	patches	and	through	 intestinal	enterocytes	 (Bellmann	et	al.,	2015).		
Following	 translocation	 through	 the	 GI	 epithelial	 layer	 a	 NM	 will	 enter	 into	 the	 lymph	 fluid	 and	
potentially	drain	 into	the	systemic	cardiovascular	system	or	be	absorbed	 into	the	capillaries	of	the	
cardiovascular	circulatory	system	(Cuong	and	Hsieh,	2011).	In	comparison	the	rate	of	NM	translocation	
following	 intravenous	 injection	 will	 differ	 significantly	 from	 the	 inhalation	 and	 oral	 ingestion.	














fractions	 present	 in	 the	 liver	 and	 kidneys	 (0.03%).	 This	 study	 demonstrated	 the	 variation	 NP	
translocation	depending	on	exposure	route	however	also	importance	is	the	biopersistence	of	the	test	
material	 regardless	 of	 how	 it	 was	 administered.	 This	 consequently	 shows	 how	 toxicological	
consideration	 must	 also	 be	 given	 to	 regions	 of	 the	 body	 other	 than	 the	 specific	 target	 of	 a	













enhancement	of	 imaging	 techniques	 (He	et	 al.,	 2015,	 Jain	 et	 al.,	 2015,	 Estelrich	 et	 al.,	 2015).	 This	





have	made	 them	 an	 ideal	 candidate	 for	 several	 biomedical	 applications.	 	 These	 include	magnetic	





due	 to	 the	 superparamagnetic	 behaviour	 SPIONs	 exert.	 The	 induced	 magnetic	 movement	 of	 the	






drug	 toxicity	 (Mahmoudi	 et	 al.,	 2011).	 	 Similarly,	 the	 ability	 of	 the	material	 to	 be	 localised	 in	 this	

























For	 example,	 elevated	 IL-8	 and	 IL-6	 expression	 occurs	 in	 normal	 epidermal	 keratinocytes	 (HEK)	






elevations	 in	 a	 glutathione	 disulphate	 (GSSG)	 to	 glutathione	 (GSH)	 ratio	 and	 a	 reduction	 in	
ferric/reducing	antioxidant	power.	Similarly,	aerosol	exposure	of	uncoated	Fe3O4	NPs	of	Wistar	rats	
over	4	weeks	resulted	in	substantial	neutrophil	 influx	into	the	alveolar	region	of	the	lung	alongside	
oxidative	stress	quantified	by	 increased	8-hydroxy-2'	 -deoxyguanosine	(8-OHdG)	 levels	 (Ahamed	et	
al.,	2013).	 	The	ability	of	SPION	to	activate	 immunological	pathways	demonstrates	 the	 importance	













et	 al.,	 2015).	Moreover,	 a	 recent	 study	 comparing	metal	 oxide	NP	 genotoxicity	 in	 primary	 human	
lymphocytes,	uncoated	γ-Fe2O3	promoted	ROS	generation	and	subsequent	genotoxicity	quantified	
by	 the	 single-cell	 gel	 electrophoresis	 assay	 (comet	 assay)	 (Rajiv	 et	 al.,	 2016).	 Fe3O4	 SPIONs	 have	
however	also	be	shown	to	be	genotoxic,	differing	 from	the	study	conducted	by	Singh	et	al	 (2012).	






















































manufacture	within	 an	 occupational	 environment.	 Analysis	was	 performed	using	 the	Hitachi	Ultra	
High	 Resolution	 field	 emission	 (FE)-SEM	 model	 number:	 S-4800	 at	 Swansea	 University,	 images	
captured	and	provided	by	Michael	J	Burgum.		
The	 functionalisation	 of	 graphene,	 graphene-oxide	 (GO)	 and	 reduced	GO	 (rGO)	 have	 been	widely	
explored	as	potential	anti-cancer	 therapeutics	with	coatings	 including	polyethylene	glycol	 (PEG)	 to	
maintain	 biocompatibility	 as	 well	 as	 acutely	 potent	 drugs	 such	 as	 doxorubicin.	 The	 various	
combinations	of	graphene	and	targeted	applications	can	be	summarised	below	as	each	pertain	to	the	
treatment	of	cancer	(Orecchioni	et	al.,	2015).		
Table	 1.	 The	 various	 applications	 of	 functionalised	 graphene	 as	 nanotheranostics,	 adapted	 from	
(Orecchioni	et	al.,	2015).	The	nature	of	the	material	and	the	therapeutic	agent	it	carries	can	specifically	
alter	the	targeting	of	the	material	as	well	as	the	function	and	target	cell	type.		
Application	 Cancer	Type	 Model	 Graphene	Therapeutic	
Drug	 Delivery	 &	
Imaging	
Burkitt’s	Lymphoma	 Human	In	Vitro	 GO-Doxorubicin	 +	




Breast	Cancer	 Mouse	In	Vivo	 PEGylated	 nano-
graphene	 sheets	 (nGS-
PEG)	(Yang	et	al.,	2012)	

















ii) Carbon	 nanotubes	 (CNTs),	 similarly	 to	 graphene	 possess	 numerous	 PCCs	 which	make	
them	choice	 selections	as	 theranostics,	high	 surface	area	 for	 functionalisation	and	NIR	





µg	 CNTs/mouse	 (equivalent	 to	 3.6	 mg/kg)	 was	 administered	 and	 revealed	 significant	
tumour	 elimination	 with	 no	 toxic	 side	 effects,	 notably	 this	 result	 closely	 resembled	 a	





Figure	 3.	 Scanning	 electron	 microscope	 images	 of	A)	 water-dispersed	 CNTs	 30	 µm	 and	 B)	 5	 µm	
resolution.	CNTs	dispersed	in	this	manner	commonly	associate	into	‘bird	nest’	agglomerates	and	pose	
a	significant	biological	hazard	in	this	biopersistent	arrangement	making	enzymatic	clearance	difficult.	




poses	 toxicity	 issues,	 which	 can	 stem	 from	 nanoparticle	 size,	 surface	 area	 and	 functionalisation.	
Carbon	nanomaterials,	particularly	graphene	and	CNTs	possess	 these	toxicity	capabilities,	however	




tendencies?	 In	 vitro	 exposure	 studies	 with	 graphene	 and	 CNTs	 have	 revealed	 cytotoxicity,	
genotoxicity,	immune-cell	activation	and	oxidative	stress	to	be	common	themes	throughout	with	bio	
persistence	 likely	 a	 contributing	 factor	 (Sanchez	 et	 al.,	 2009).	 The	 manipulation	 of	 carbon-based	
nanotheranostics	 in	 vivo	 therefore	 becomes	 pivotal	 at	 two	 control	 points;	 bio-persistence	 and	
clearance	 both	 of	 which	 tightly	 associate	 with	 their	 pathogenicity,	 similar	 to	 asbestos.	 The	 bio-
persistence	of	these	materials	is	fundamentally	correlated	with	their	tendency	to	agglomerate	thus	
making	 nanomaterial	 clearance	 by	 macrophages	 and	 neutrophils	 much	 more	 difficult.	 The	
degradation,	largely	in	the	form	of	peroxidase	enzymes	released	by	immune	neutrophils	(Kotchey	et	
al.,	 2013)	 is	 generally	 accepted	 in	 literature	 as	 the	 primary	 means	 of	 carbon-based	 material	
degradation	in	vivo	however	other	mechanisms	likely	play	a	role	in	assisted	clearance.	It	has	also	been	
reported	that	controlled	respiratory	burst	by	macrophages	containing	 lignin	peroxidase	can	 induce	
biodegradation	 in	 single-walled	 carbon	 nanotubes	 (SWCNTs),	 it	 was	 later	 hypothesised	 that	 the	
biodegraded	products	would	induce	a	weaker	immune	response	(Hou	et	al.,	2016).	Following	the	use	




the	 carbon-based	 structures.	 These	 findings	 are	 likely	 to	 be	 beneficial	 during	 the	 design	 and	 safe	













highly	 resistant	 photo-bleaching	 capabilities	 (Medintz	 et	 al.,	 2008).	 In	 addition	 to	 the	 increased	
stability	 of	 quantum	dots	 over	 conventional	 fluorescent	 dyes	 used	 in	 traditional	 biological	 assays,	
quantum	dots	are	engineered	to	exhibit	a	wider	range	of	excitation	and	emission	wavelengths	(Lovric	
et	al.,	2005).	Microscopic	observations	of	these	particles	have	revealed	an	on-off	blinking	omission	
characteristic	 however	 current	 advances	 in	 this	 technology	 specifically	 engineering	 alloyed	
composition	 from	 the	 core	 to	 the	quantum	dot	 surface	 can	 greatly	 enhance	 the	omission	 to	 now	
remain	consistently	“on”	 (Smith	and	Nie,	2009).	Quantum	dot	composition	can	 fluctuate	widely	 in	




and	bulk	nano	crystal	quantum	dots	 (NQDs)	under	experimental	 conditions.	 These	problems	 stem	
from	 the	 surface	 chemistry	 of	 the	 crystalline	 shell	which	 after	 interacting	with	 the	 environmental	
physiology	can	greatly	affect	the	emission	spectra	of	these	molecules.	This	study	overcame	the	issue	
by	manufacturing	 ‘giant’	 Cadmium	 selenide	 (CdSe)	 quantum	 dots	 possessing	 an	 overly	 large	 shell	
consequently	 placing	 a	 sufficiently	 large	 gap	 between	 photo	 luminescent	 function	 and	 surface	





Biological	 applications	 of	 quantum	 dots	 requires	 stable	 dispersion	 in	 aqueous	 media,	
tolerability	 to	 neutral,	 acidic	 and	basic	 pH	 ranges	 and	 ideally	 are	water	 soluble.	With	 advances	 in	
nanotheranostics	 in	mind	 there	now	exist	 numerous	effective	 strategies	 for	 producing	hydrophilic	
quantum	dots	post-synthesis,	these	two	categories	are;	complete	cap	exchange	and	native	surface	




1998).	 Designing	 a	 multifunctional	 nanotheranostic	 utilising	 quantum	 dots	 can	 theoretically	
accomplish	precision	diagnosis	with	effective	 treatment	 typically	as	anti-tumour	agents,	 this	 is	 the	
case	 with	 Tungsten	 sulphide	 quantum	 dots	 which	 remain	 under	 optimisation	 in	 delivering	



























however	 as	 quantum	 dots,	 either	 at	 the	 time	 of	 delivery	 or	 over	 a	 chronic	 exposure	 period	may	
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nano	 crystal	 core	 can	



















It	 is	 vital	 that	 these	
models	 incorporate	























With	 the	 heightened	 interest	 and	 influx	 of	 funding,	 nanotheranostics	 will	 likely	 receive	 far	 more	
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